Last updated: 13 days ago
AstraZeneca's Enhertu: Breakthrough Findings in Breast Cancer Treatment
Discover AstraZeneca's Enhertu's promising trial results for HER2-positive early breast cancer, showcasing significant survival improvements and plans for regulatory approval.